Chronic administration of an angiotensin II receptor antagonist resets the hypothalamic–pituitary–adrenal (HPA) axis and improves the affect of patients with diabetes mellitus type 2: Preliminary results

Research Report

Maria G. Pavlatou First Department of Pediatrics, Athens University Medical School, Athens, 11527, GreeceCorrespondence[email protected]

George Mastorakos Endocrine Unit, Second Department of Obstetrics and Gynecology, Athens University Medical School, Athens, 11528, Greece

Ioannis Lekakis Second Department of Cardiology, Athens University Medical School, Athens, 12462, Greece

Stavros Liatis First Department of Propaedeutic Medicine, Athens University Medical School, Athens, 11527, Greece

Georgia Vamvakou Second Department of Cardiology, Athens University Medical School, Athens, 12462, Greece

Emmanuel Zoumakis First Department of Pediatrics, Athens University Medical School, Athens, 11527, Greece

Ioannis Papassotiriou Department of Clinical Biochemistry, “Aghia Sophia” Children's Hospital, Athens, 11527, Greece

Andreas D. Rabavilas University Mental Health Research Institute, Athens, 15669, Greece

Nikolaos Katsilambros First Department of Propaedeutic Medicine, Athens University Medical School, Athens, 11527, Greece

George P. Chrousos First Department of Pediatrics, Athens University Medical School, Athens, 11527, Greece